Does Insurance Cover Spravato in Ohio? Everything You Need to Know
-
Does Insurance Cover Spravato in Ohio?
Why Insurance Covers Spravato
Who Qualifies for Insurance Coverage?
Which Ohio Insurance Plans Cover Spravato?
Medicare Coverage
Ohio Medicaid Coverage
Medical Benefit vs. Pharmacy Benefit
How Prior Authorization Works
What Happens if Insurance Denies Coverage?
Ways to Reduce Out-of-Pocket Costs
How Amazing Grace Center Helps Patients Navigate Insurance
Frequently Asked Questions
Does Insurance Cover Spravato in Ohio?
The short answer is yes. Spravato® (esketamine) is covered by most major insurance providers in Ohio when it is prescribed for an FDA-approved indication and your insurance company’s medical necessity requirements are met. This includes many commercial insurance plans such as Anthem Blue Cross Blue Shield, Medical Mutual of Ohio, Aetna, Cigna, UnitedHealthcare, Humana, many employer-sponsored health plans, Ohio Medicaid managed care plans, and Medicare Part B. Coverage policies vary by plan, but most require prior authorization before treatment begins.
Unlike intravenous (IV) ketamine infusions, which are prescribed off-label for depression and are often considered experimental by insurers, Spravato occupies a unique position. It is an FDA-approved medication with established treatment protocols, allowing many insurance companies to provide benefits for eligible patients. This distinction is one of the primary reasons Spravato is accessible to many individuals who could not otherwise afford rapid-acting depression treatment.
If you have been diagnosed with treatment-resistant depression or major depressive disorder with acute suicidal thoughts or behaviors, your insurance may help cover a significant portion of treatment costs once authorization has been approved.
This guide explains how Spravato coverage works in Ohio, who typically qualifies, which insurers commonly provide benefits, what prior authorization involves, and how Amazing Grace Center helps patients navigate the insurance process from beginning to end.
Why Insurance Covers Spravato
Insurance companies generally cover medications that have demonstrated safety and effectiveness through rigorous clinical research and have received approval from the U.S. Food and Drug Administration. Spravato received FDA approval in 2019 for adults with treatment-resistant depression and later for adults with major depressive disorder accompanied by acute suicidal ideation or behavior. In 2025, the FDA also approved Spravato as the first standalone treatment for treatment-resistant depression, meaning it no longer must be used together with an oral antidepressant in every case.
Because Spravato has FDA approval for these specific conditions, insurers frequently consider it a medically appropriate treatment when standard antidepressants have not provided sufficient relief. This differs substantially from IV ketamine or intramuscular ketamine injections, which remain off-label treatments for depression and are therefore excluded from coverage under many insurance policies.
Insurance companies also recognize that Spravato must be administered in a REMS-certified medical clinic under direct supervision. Patients are monitored for at least two hours after each treatment because temporary increases in blood pressure, sedation, or dissociation can occur. The structured nature of treatment helps insurers ensure the medication is being used safely and according to FDA guidelines.
Who Qualifies for Insurance Coverage?
Although many insurance companies cover Spravato, approval is not automatic. Most insurers require documentation demonstrating that treatment is medically necessary before authorization is granted.
The first requirement is typically a diagnosis of treatment-resistant depression (TRD). In most cases, this means you have experienced major depressive disorder and have not achieved adequate improvement after trying at least two different antidepressants from different medication classes at therapeutic doses for an appropriate duration.
Many insurance plans also require documentation of symptom severity. Your psychiatrist may administer standardized depression rating scales such as the PHQ-9, Montgomery-Åsberg Depression Rating Scale (MADRS), or Hamilton Depression Rating Scale (HDRS) to objectively measure the severity of your symptoms and monitor improvement throughout treatment.
Patients must generally be at least 18 years old and complete a comprehensive psychiatric evaluation to determine whether Spravato is appropriate. Your provider will also review your medical history for conditions that may increase treatment risks, including certain vascular disorders, aneurysms, uncontrolled hypertension, or other contraindications identified in the prescribing information.
Finally, treatment must be provided through a clinic certified under the Spravato REMS (Risk Evaluation and Mitigation Strategy) Program, which is required by the FDA for every patient receiving Spravato in the United States.
Which Ohio Insurance Plans Cover Spravato?
Many of Ohio’s largest commercial insurance companies provide coverage for Spravato when medical necessity criteria are satisfied and prior authorization has been approved. Individual employer plans and marketplace plans may have different requirements, but coverage is commonly available through insurers including:
Anthem Blue Cross Blue Shield
Medical Mutual of Ohio
Aetna
Cigna
UnitedHealthcare
Humana
Many employer-sponsored commercial insurance plans
Although every insurer uses its own prior authorization criteria, most evaluate similar information, including previous antidepressant trials, diagnosis, symptom severity, psychiatric evaluation, and confirmation that treatment will occur in a REMS-certified facility. Many plans also require periodic reauthorization after the initial induction phase to document continued clinical improvement.
Some employer-sponsored plans administer their pharmacy benefits through organizations such as CarelonRx, CVS Caremark, Express Scripts, or OptumRx. These pharmacy benefit managers may use slightly different documentation requirements while still following the same general medical necessity standards.
Regardless of your insurance company, verifying benefits before beginning treatment helps avoid unexpected costs and delays. At Amazing Grace Center, our team completes this verification process before your first treatment whenever possible.
Medicare Coverage for Spravato in Ohio
Medicare beneficiaries may also qualify for Spravato coverage. Because Spravato is administered in a certified medical office rather than dispensed for home use, it is generally covered under Medicare Part B instead of Medicare Part D. This distinction is important because Part B covers physician-administered medications and the associated medical services provided during treatment.
Once the annual Medicare Part B deductible has been met, Medicare typically pays 80% of the approved amount, leaving the patient responsible for the remaining coinsurance unless they have supplemental coverage. Many individuals enrolled in a Medigap (Medicare Supplement) plan or a Medicare Advantage plan have significantly lower out-of-pocket expenses depending on their specific policy.
Because every Medicare Advantage plan has its own authorization requirements, it is important to verify benefits before beginning treatment. Some plans require prior authorization, while others may require treatment at an in-network REMS-certified provider.
Patients covered by Medicare should also know that federal regulations prevent the use of the manufacturer’s commercial copay savings program. However, other financial assistance options may be available depending on individual circumstances.
Ohio Medicaid Coverage
Spravato is also covered by Ohio Medicaid for eligible patients when medical necessity requirements are met. Coverage is administered through Ohio’s Medicaid managed care organizations, each of which maintains its own authorization process while following state and federal coverage requirements.
Ohio Medicaid managed care plans include:
AmeriHealth Caritas Ohio
Anthem Blue Cross Blue Shield Ohio Medicaid
Buckeye Health Plan
CareSource Ohio
Humana Healthy Horizons in Ohio
Molina Healthcare of Ohio
UnitedHealthcare Community Plan of Ohio
For many Medicaid recipients, out-of-pocket costs for Spravato treatment are minimal or may be fully covered after authorization has been approved. Although financial barriers are often lower than with commercial insurance, prior authorization is still typically required before treatment begins.
Your psychiatrist must document your diagnosis, previous treatment history, medical necessity, and eligibility for Spravato. Each managed care organization may request slightly different supporting documentation, making experienced administrative support an important part of the approval process.
Medical Benefit vs. Pharmacy Benefit: Why It Matters
One aspect of insurance coverage that often surprises patients is that Spravato may be covered under either the medical benefit or the pharmacy benefit, depending on how an insurance plan is structured.
Under the medical benefit, both the medication and the in-office administration are typically billed as part of your medical treatment. This often means your deductible, coinsurance, or office visit benefits determine your out-of-pocket responsibility.
Other insurance plans classify Spravato as a specialty medication under the pharmacy benefit. In these situations, the medication itself may be processed separately from the clinical monitoring and observation provided during your appointment. This can result in different copays or coinsurance amounts for the medication and the office visit.
Understanding which benefit applies to your policy helps avoid confusion when treatment begins. Before your first appointment, it is helpful to ask your insurance company:
Is Spravato covered under my medical benefit or pharmacy benefit?
What deductible applies?
What will my coinsurance or copayment be?
Does prior authorization need to be renewed during treatment?
At Amazing Grace Center, our staff reviews these details with your insurance company before treatment whenever possible so you have a clear understanding of your expected financial responsibility.
How Prior Authorization Works
Nearly every insurance company requires prior authorization before approving Spravato treatment. Although the process may sound intimidating, it is a routine part of care, and experienced psychiatric practices complete these requests regularly.
The process usually begins with a comprehensive psychiatric evaluation. During this appointment, your provider confirms your diagnosis, reviews your previous antidepressant trials, evaluates symptom severity, and determines whether Spravato is an appropriate treatment option.
Once eligibility has been established, supporting documentation is gathered. This typically includes your psychiatric diagnosis, previous medications, treatment duration, dosage history, depression rating scale scores, and a detailed explanation of why Spravato is medically necessary.
The completed authorization request is then submitted to your insurance company or pharmacy benefit manager for review. Most insurers respond within one to three weeks, although urgent requests may occasionally be processed more quickly. If additional documentation is requested, your provider’s office communicates directly with the insurance company to supply the necessary information.
After approval, treatment sessions can be scheduled according to the recommended induction protocol. Depending on your insurance plan, periodic reauthorization may be required to demonstrate continued clinical benefit before maintenance treatment continues.
At Amazing Grace Center, our team manages the prior authorization process on behalf of our patients. We work directly with insurance companies to verify benefits, submit required documentation, and communicate updates throughout the approval process, allowing patients to focus on treatment rather than paperwork.
What If Your Insurance Denies Spravato?
Receiving an insurance denial can be discouraging, but it does not necessarily mean Spravato will never be covered. Many initial denials are related to incomplete documentation rather than a determination that treatment is inappropriate. In many cases, additional clinical information is enough to reverse the decision.
Common reasons for denial include insufficient documentation of previous antidepressant trials, missing clinical records, incomplete prior authorization forms, or a request for additional information supporting medical necessity. Some insurers may also request standardized depression rating scales or clarification regarding previous treatments before making a final determination.
When a denial occurs, your psychiatrist can submit a formal appeal. This process typically includes updated medical records, additional documentation of prior treatment failures, a detailed letter explaining why Spravato is medically necessary, and, when appropriate, a peer-to-peer review between your psychiatrist and the insurance company’s medical reviewer.
Many appeals are successful once all requested documentation has been provided. Because the process can be time-consuming, working with a clinic experienced in Spravato treatment can significantly reduce delays and improve the likelihood of approval.
Ways to Reduce Your Out-of-Pocket Costs
Even when insurance covers Spravato, deductibles, copayments, and coinsurance can still result in out-of-pocket expenses. Fortunately, several programs may help reduce the financial burden for eligible patients.
For individuals with commercial insurance, the SPRAVATO® withMe Savings Program may significantly lower medication costs for those who qualify. Eligibility requirements are established by the manufacturer, and the program is generally available only to patients with commercial or employer-sponsored insurance. Individuals enrolled in Medicare, Medicaid, TRICARE, or other government-funded insurance programs are not eligible due to federal regulations.
Some patients without adequate insurance coverage may qualify for the manufacturer’s patient assistance program, which may provide medication at reduced or no cost depending on financial eligibility.
Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) may also be used to pay eligible medical expenses related to Spravato treatment, including deductibles, copayments, and coinsurance.
Because every insurance plan is different, discussing expected costs before treatment begins helps patients make informed decisions and avoid unexpected expenses.
How Amazing Grace Center Helps Patients Navigate Insurance
Beginning Spravato treatment involves more than scheduling an appointment. Insurance verification, prior authorization, REMS enrollment, and treatment planning all occur before the first dose is administered. Managing these steps efficiently helps prevent unnecessary delays and allows patients to begin treatment as quickly as possible.
At Amazing Grace Center in Portsmouth, Ohio, our team assists patients throughout the insurance approval process. Before treatment begins, we verify your insurance benefits, determine whether Spravato is covered under your medical or pharmacy benefit, review anticipated deductibles and copayments, and submit prior authorization documentation to your insurance company when required.
If additional information is requested by your insurance carrier, we work directly with the reviewer to provide the necessary clinical documentation. Should coverage initially be denied, our providers assist with the appeals process by submitting supporting medical records, letters of medical necessity, and additional documentation that demonstrates why Spravato is an appropriate treatment option.
Our goal is to simplify the insurance process so patients can focus on what matters most—improving their mental health. Whether you have commercial insurance, Medicare, or Ohio Medicaid, our staff is available to answer questions, explain your benefits, and help you understand what to expect before treatment begins.
If you are considering Spravato for treatment-resistant depression, we encourage you to schedule a psychiatric evaluation. During your consultation, we will review your treatment history, determine whether you may be a candidate for Spravato, and discuss all available treatment options.
Frequently Asked Questions about Spravato Coverage in Ohio
-
Yes. Most major commercial insurance companies in Ohio, including Anthem Blue Cross Blue Shield, Medical Mutual, Aetna, Cigna, UnitedHealthcare, and Humana, provide coverage for Spravato when medical necessity requirements are met. Spravato is also covered by Medicare Part B and Ohio Medicaid for eligible patients, although prior authorization is typically required.
-
Yes. Ohio Medicaid covers Spravato for eligible patients through its managed care organizations. Coverage generally requires prior authorization, documentation of treatment-resistant depression, and treatment at a REMS-certified clinic.
-
Yes. Because Spravato is administered in a healthcare setting, it is generally covered under Medicare Part B rather than Part D. Depending on your supplemental insurance or Medicare Advantage plan, your out-of-pocket costs may vary.
-
Most insurance companies issue prior authorization decisions within one to three weeks after receiving all required documentation. Delays most often occur when additional medical records or clarification are requested.
-
Not necessarily. In 2025, the FDA approved Spravato as a standalone treatment for adults with treatment-resistant depression. However, some insurance companies may still have policies that were developed before this approval. Your psychiatrist can review your individual situation and verify your plan’s current requirements.
-
Having tried multiple antidepressants without significant improvement may strengthen your eligibility for Spravato. Your psychiatrist will review your medication history and determine whether you meet the clinical criteria used by most insurance companies.
-
Some insurance plans have step therapy or prior authorization requirements that require documentation of previous treatments before approving Spravato. The specific requirements depend on your individual insurance policy and may differ between commercial insurance, Medicare, and Medicaid.
-
Yes. Our team assists patients by verifying insurance benefits, completing prior authorization requests, communicating with insurance companies, and helping coordinate appeals if additional documentation is needed.
Key Takeaways
Spravato has become an important treatment option for adults living with treatment-resistant depression because it offers a rapid-acting, FDA-approved therapy that is covered by many insurance plans. Unlike off-label ketamine infusions, Spravato is recognized by most commercial insurers, Medicare Part B, and Ohio Medicaid when established medical necessity criteria are met.
Although prior authorization is usually required, many patients qualify for coverage after documentation of previous antidepressant treatment, symptom severity, and psychiatric evaluation has been submitted. Understanding your insurance benefits before beginning treatment can reduce delays and provide a clearer picture of expected costs.
At Amazing Grace Center in Portsmouth, Ohio, we are committed to making the process as straightforward as possible. From comprehensive psychiatric evaluations and REMS-certified Spravato treatment to insurance verification and prior authorization support, our team is here to help you access evidence-based care with confidence. If you are living with treatment-resistant depression and would like to learn whether Spravato may be right for you, contact Amazing Grace Center to schedule a consultation with Dr. Olivetta Uradu and our experienced mental health team.
Read more about Spravato for depression:
